LucenceINSIGHT
Multi‑cancer early detection (up to 50 cancers)
CommercialActive
Key Facts
Indication
Multi‑cancer early detection (up to 50 cancers)
Phase
Commercial
Status
Active
Company
About Lucence Diagnostics
Singapore‑born precision‑diagnostics firm delivering AI‑enhanced liquid‑biopsy and early‑cancer detection tests.
View full company profile